title: Haemagglutinin mutations and glycosylation changes shaped the 2012/13 influenza A(H3N2) epidemic, Houston, Texas.
abstract: While the early start and higher intensity of the 2012/13 influenza A virus (IAV) epidemic was not unprecedented, it was the first IAV epidemic season since the 2009 H1N1 influenza pandemic where the H3N2 subtype predominated. We directly sequenced the genomes of 154 H3N2 clinical specimens collected throughout the epidemic to better understand the evolution of H3N2 strains and to inform the H3N2 vaccine selection process. Phylogenetic analyses indicated that multiple co-circulating clades and continual antigenic drift in the haemagglutinin (HA) of clades 5, 3A, and 3C, with the evolution of a new 3C subgroup (3C-2012/13), were the driving causes of the epidemic. Drift variants contained HA substitutions and alterations in the potential N-linked glycosylation sites of HA. Antigenic analysis demonstrated that viruses in the emerging subclade 3C.3 and subgroup 3C-2012/13 were not well inhibited by antisera generated against the 3C.1 vaccine strains used for the 2012/13 (A/Victoria/361/2011) or 2013/14 (A/Texas/50/2012) seasons. Our data support updating the H3N2 vaccine strain to a clade 3C.2 or 3C.3-like strain or a subclade that has drifted further. They also underscore the challenges in vaccine strain selection, particularly regarding HA and neuraminidase substitutions derived during laboratory passage that may alter antigenic testing accuracy.
authors.affiliation: Virology Group, J. Craig Venter Institute, Rockville, Maryland, United States.
authors.forename: K M
authors.initials: KM
authors.lastname: Stucker
authors.forename: S A
authors.initials: SA
authors.lastname: Schobel
authors.forename: R J
authors.initials: RJ
authors.lastname: Olsen
authors.forename: H L
authors.initials: HL
authors.lastname: Hodges
authors.forename: X
authors.initials: X
authors.lastname: Lin
authors.forename: R A
authors.initials: RA
authors.lastname: Halpin
authors.forename: N
authors.initials: N
authors.lastname: Fedorova
authors.forename: T B
authors.initials: TB
authors.lastname: Stockwell
authors.forename: A
authors.initials: A
authors.lastname: Tovchigrechko
authors.forename: S R
authors.initials: SR
authors.lastname: Das
authors.forename: D E
authors.initials: DE
authors.lastname: Wentworth
authors.forename: J M
authors.initials: JM
authors.lastname: Musser
mesh_terms: D058872:Epidemics; D005260:Female; D040961:Genetic Drift; D006031:Glycosylation; D019267:Hemagglutinin Glycoproteins, Influenza Virus / Q000235:genetics*; D006388:Hemagglutinins / Q000235:genetics*; D006801:Humans; D053122:Influenza A Virus, H3N2 Subtype / Q000276:immunology; D007251:Influenza, Human / Q000453:epidemiology*; D009154:Mutation; D010802:Phylogeny; D012367:RNA, Viral / Q000235:genetics / Q000302:isolation & purification; D017422:Sequence Analysis, DNA; D013781:Texas / Q000453:epidemiology
chemical_list: D019267:Hemagglutinin Glycoproteins, Influenza Virus; D006388:Hemagglutinins; D012367:RNA, Viral